🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Breast Cancer (Early Breast Cancer)

CtDNA Based MRD Testing for NAC Monitoring in TNBC NCT06230185n/a14 sites📍 Tucson📍 Aurora📍 Washington D.C. Personalis Inc. Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy NCT07386444NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Inspiratory muscle training Validation of the Oncoliq Test for the Early Detection of Breast Cancer. NCT07331506n/a1 site📍 Buenos Aires Oncoliq US Inc · Tests: Peripheral blood draw The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer NCT04291378NA8 sites📍 Aalborg📍 Aarhus📍 Copenhagen Danish Breast Cancer Cooperative Group · Tests: Proton versus photon radiation therapy Evaluation of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT for Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in HER2 Positive Early Breast Cancer NCT07593976Phase 21 site📍 Rouen Centre Henri Becquerel · Tests: [68Ga]Ga-NOTA-anti-HER2-sdAb Positron Emission Tomography Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Cancers NCT07233928NA1 site📍 Toulouse Institut Claudius Regaud · Tests: Tumor biopsy Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial) NCT07629206NA3 sites📍 Glendale📍 Portland📍 Germantown IceCure Medical Ltd. · Tests: Cryoablation Luminal Breast Cancer Cryoablation NCT07447414NA1 site📍 Lugo Lucía Graña López · Tests: Cryoablation with liquid nitrogen (Prosense® system) ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness NCT07084558NA14 sites📍 Vienna📍 Baden📍 Dornbirn Austrian Breast & Colorectal Cancer Study Group · Tests: blood sample for Signatera (TM) test, biopsy for Ki-67 assessment, FFPE tumor sample for Signatera (TM) test (archived) Diet Modification in pAtients With Luminal Early Breast Cancer Candidate for Primary Surgery NCT04469296NA1 site📍 Montpellier Institut du Cancer de Montpellier - Val d'Aurelle · Tests: iso-caloric ketogenic diet, protein restricted diet AI-Assisted Non-Contrast CT for Multi-Cancer Screening NCT06632886NA1 site📍 Shanghai Guo ShiWei · Tests: AI-Assisted Non-Contrast CT for Multi-Cancer Screening Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients NCT05350722NA7 sites📍 Sydney📍 Almere Stad📍 Amstelveen Amsterdam UMC, location VUmc · Tests: Single dose ablative radiotherapy MELIORA Data Collection Campaigns NCT07190066NA7 sites📍 Athens📍 Kaunas📍 Kaunas Harokopio University · Tests: Data Collection campaign The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer NCT06698679n/a1 site📍 Shenyang Shengjing Hospital · Tests: No intervention Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer NCT07327970n/a1 site📍 Incheon Young-Joon Kang · Tests: multi-modal foundation AI test PARTial BREast RECONstruction With Chest Wall Perforator Flap NCT06728527n/a1 site📍 Cambridge Cambridge University Hospitals NHS Foundation Trust Cardiometabolic Screening Program NCT05386719NA1 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Prescreening, Screening and Enrollment, Baseline, Interpret BMI, Interpret HbA1c Predicting Response to Immunochemotherapy in Early Triple Negative Breast Cancer NCT07570524n/a1 site📍 Rennes Center Eugene Marquis · Tests: Additionnal breast biospy and blood sample Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation NCT05761470Phase 21 site📍 Guangzhou Ying Lin · Tests: Camrelizumab, Fluzoparib, Nab-paclitaxel Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence. NCT07443774n/a1 site📍 Grenoble University Hospital, Grenoble Neoadjuvant Pyrotinib-to-pertuzumab in HER2+ eBC NCT07797218Phase 31 site📍 Shanghai Shanghai Jiao Tong University School of Medicine · Tests: Docetaxel, Pyrotinib, Trastuzumab (Herceptin), Pertuzumab Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Early Breast Cancer NCT05306041Phase 262 sites📍 Essen📍 Augsburg📍 Berlin GBG Forschungs GmbH · Tests: Inavolisib, PHESGO, Endocrine therapy A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer NCT04985266Phase 249 sites📍 Angers📍 Annecy📍 Avignon Royal Marsden NHS Foundation Trust · Tests: Palbociclib 125Mg Tab, Fulvestrant injection, Tamoxifen, Letrozole, Exemestane A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs) NCT07743190Phase 22 sites📍 Syracuse📍 Charleston Medical University of South Carolina · Tests: Carboplatin, Paclitaxcel, Pembrolizumab Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy NCT01185132Phase 35 sites📍 Aurora📍 Boulder📍 Lakewood Rocky Mountain Cancer Centers · Tests: accelerated partial breast irradiation - 3D-conformal planning, accelerated partial breast irradiation - IMRT planning A Study of the TheraBionic P1 Device in Breast Cancer NCT07218432NA8 sites📍 Clarkston📍 Detroit📍 Farmington Hills Barbara Ann Karmanos Cancer Institute · Tests: TheraBionic P1 Device Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer NCT06220214EARLY Phase 11 site📍 Stony Brook Alison Stopeck · Tests: CEDM, CEDBT, Omnipaque 350mgI/mL Solution for Injection Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy NCT05989347Phase 11 site📍 New Haven Yale University · Tests: Dapagliflozin 10mg A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer NCT06508216Phase 1, Phase 21 site📍 Villejuif Gustave Roussy, Cancer Campus, Grand Paris · Tests: Dato-DXd, Durvalumab Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib NCT07237256Phase 3138 sites📍 Amiens📍 Angers📍 Argenteuil UNICANCER · Tests: Chemotherapy followed by endocrine therapy and ribociclib treatment, De-escalation
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy